prof.dr. S. Siesling (Sabine)

Full Professor

About Me

Sabine Siesling, clinical epidemiologist, is professor ‘Outcomes Research and Personalized cancer care’ at the University of Twente and senior researcher at the Netherlands Comprehensive Cancer Organisation (IKNL). She focusses on the effect of interventions, such as care pathways or implementation of new technologies, on the quality, organisation and outcome of cancer care. She tailors care and follow-up using/developing prediction models which are based on data from e.g. the Netherlands Cancer registry. She is board member of the National breast cancer working group (NABON) and the NABON Breast cancer audit and PROMS sections, and the European Initiative on Breast cancer Care-Quality assurance Development group. Moreover, she leads the program on Women’s Health at the University of Twente.  

She has been president of the Netherlands Epidemiological Society 


Medicine & Life Sciences
Breast Neoplasms

Ancillary Activities

  • Integraal Kankercentrum Nederland (IKNL)


Verrijssen, A-SE. , Evers, J., van der Sangen, M. , Siesling, S., Aarts, M. J., Struikmans, H., Bloemers, M. C. W. M., Burger, J., & Lemmens, V. (2024). Trends and Variation in the Use of Radiotherapy in Non-metastatic Rectal Cancer: a 14-year Nationwide Overview from the Netherlands. Clinical oncology. Advance online publication. https://doi.org/10.1016/j.clon.2024.01.013
Slotman, E., Fransen, H. P., van Laarhoven, H. W. M., van den Beuken-van Everdingen, M. H. J., Tjan-Heijnen, V. C. G., Huijben, A. M. T., Jager, A., van Zuylen, L., Kuip, E. J. M., van der Linden, Y. M., Raijmakers, N. J. H. , & Siesling, S. (2024). Reduction in potentially inappropriate end-of-life hospital care for cancer patients during the COVID-19 pandemic: A retrospective population-based study. Palliative Medicine, 38(1), 140-149. https://doi.org/10.1177/02692163231217373
Wang, Y., Dackus, G. M. H. E., Rosenberg, E. H., Cornelissen, S., de Boo, L. W., Broeks, A., Brugman, W., Chan, T. W. S., van Diest, P. J., Hauptmann, M., ter Hoeve, N. D., Isaeva, O. I., de Jong, V. M. T., Jóźwiak, K., Kluin, R. J. C., Kok, M., Koop, E., Nederlof, P. M., Opdam, M., ... Schmidt, M. K. (2024). Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status. BMC Medicine, 22, Article 9. Advance online publication. https://doi.org/10.1186/s12916-023-03233-7
de Wild, S. R., Koppert, L. B., de Munck, L., Vrancken Peeters, M. J. T. F. D. , Siesling, S. , Smidt, M. L., & Simons, J. M. (2023). Prognostic effect of nodal status before and after neoadjuvant chemotherapy in breast cancer: a Dutch population-based study. Breast cancer research and treatment. Advance online publication. https://doi.org/10.1007/s10549-023-07178-6
Hagenaars, B. , & Siesling, S. (2023). Gelijke en begrijpelijke borstkankerzorg voor iedereen: Verslag van de interactieve bijeenkomst 'Gelijke borstkankerzorg voor iedereen'. Paper presented at Gelijke borstkankerzorg voor iedereen, Utrecht, Netherlands.
Arndt, V. , & Siesling, S. (2023). Krebsregistrierung in Europa. Die Onkologie. Advance online publication. https://doi.org/10.1007/s00761-023-01454-2
Beenhakker, L. , Wijlens, K. A. E. , Witteveen, A. , Bode, C. , Siesling, S. , & Vollenbroek-Hutten, M. M. R. (2023). Decision support towards optimal intervention for breast cancer patients who experience cancer-related fatigue. Abstract from 45th Annual North American Meeting of the Society for Medical Decision Making, SMDM 2023, Philadelphia, Pennsylvania, United States.
Eijkelboom, A. (2023). COVID-19 pandemic and breast cancer detection and care. [PhD Thesis - Research external, graduation UT, University of Twente]. University of Twente. https://doi.org/10.3990/1.9789036558167
Nagtegaal, I. D., Snoek, J. A. A., Bult, P., Tol, J. , Siesling, S., Voorham, Q. J., & Hugen, N. (2023). The value of case reports in rare oncological scenarios: mixed method analysis of colorectal metastases from breast cancer. Clinical and Experimental Metastasis, 40(3), 205-216. https://doi.org/10.1007/s10585-023-10207-9
Luyendijk, M., Jager, A., Buijs, S. M. , Siesling, S., Groot, C. A. U. D., & Blommestein, H. M. (2023). Cost-Effectiveness Analysis of MammaPrint® to Guide the Use of Endocrine Therapy in Patients with Early-Stage Breast Cancer. PharmacoEconomics, 41(8), 981-997. https://doi.org/10.1007/s40273-023-01277-4
Liefaard, M. C., van der Voort, A., van Ramshorst, M. S. , Sanders, J., Vonk, S., Horlings, H. M. , Siesling, S., de Munck, L. , van Leeuwen, A. E., Kleijn, M., Mittempergher, L., Kuilman, M. M., Glas, A. M., Wesseling, J., Lips, E. H., & Sonke, G. S. (2023). BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer. Breast cancer research, 25(1), Article 71. https://doi.org/10.1186/s13058-023-01664-x
Verreck, E. E. F., van Steenhoven, J. E. C., Kuijer, A. , van Maaren, M. C., Simons, J. M. , Siesling, S., & van Dalen, T. (2023). ASO Visual Abstract: Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy. Annals of surgical oncology, 30(9), 5635-5636. https://doi.org/10.1245/s10434-023-13621-1

UT Research Information System

Contact Details

Visiting Address

University of Twente
Faculty of Behavioural, Management and Social Sciences
Technohal (building no. 18), room 3105
Hallenweg 5
7522NH  Enschede
The Netherlands

Navigate to location

Mailing Address

University of Twente
Faculty of Behavioural, Management and Social Sciences
Technohal  3105
P.O. Box 217
7500 AE Enschede
The Netherlands